The Patent Finder
US

Abuse-Proofed Dosage Form

US 8,075,872 Term ended
OverviewFamilyAssignmentsSources & methods

Term ended no later than Nov 20, 2023 · Medium confidence

Filed Feb 6, 2006 as application 11/349,544 · Granted Dec 13, 2011
Base term, 20 years from filing
Today
20 years from filing
Ended no later than Nov 20, 2023
2003 2026
Clock starts
Nov 20, 2003
Ended no later than
Nov 20, 2023
Granted
Dec 13, 2011
base term after the term ends fee events Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
Unresolved
Terminal disclaimer
On file, reference document not resolved, so the date above is an upper bound. We do not guess the cap.
3 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
34
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.

This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is on file with no resolved reference, so no cap is applied and none is guessed. All three maintenance fees were paid, so no fee lapse ended it. Confidence: Medium. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Nov 20, 2003, when application 10/718,112, the earliest non-provisional in its chain, was filed (this one was filed Feb 6, 2006)Nov 20, 2023High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustmentNone on fileno changeHigh confidence
Terminal disclaimer capDisclaimer on file (approved), reference document not resolvedno cap applied, and none guessedMedium confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events3 of 3 maintenance fees paidterm endedHigh confidence
Computed term endThe steps above, in orderno later than Nov 20, 2023Medium confidence

Partial family

US 8,114,383Term ended
no later than Oct 2024
no later than Oct 2024
US 8,114,384Lapsed on the fee record
Feb 2024
Feb 2024
Application 10/890,763Abandoned
not computed
not computed
Application PCT/EP2004/008792PCT application
no patent term
no patent term
Application PCT/EP2004/014679PCT application
no patent term
no patent term
Application 11/348,295Abandoned
not computed
not computed
US 8,075,872this patent
no later than Nov 2023
no later than Nov 2023
Application 11/471,438Abandoned
not computed
not computed
8 of 34 applications in this family shown, earliest filings first. Partial: 4 of the 34 have no file history here, so a row comes from the patent's own record or names the application alone. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Jul 3, 2006
Reel 18055, frame 650
Arkenau-maric, Elisabeth; Bartholomaus, Johannes; Kugelmann, HeinrichGrunenthal GmbHAssignment of Assignor's Interest
Dec 9, 2010
Reel 25456, frame 172
Endo Pharmaceuticals Inc.JPMorgan Chase Bank, N.A., as Administrative AgentConfirmatory Grant of Security Interest in United States Patents (Exclusively Licensed Patents)
Jul 8, 2011
Reel 26561, frame 978
Endo Pharmaceuticals Inc.Morgan Stanley Senior Funding, Inc., as Administrative AgentSecurity Interest in Exclusively Licensed Patents
Jul 12, 2011
Reel 26577, frame 357
JPMorgan Chase Bank N.A., as Administrative AgentEndo Pharmaceuticals Inc.Release of Security Interest in Exclusively Licensed Patents Recorded at Reel/Frame 25456/172
Mar 3, 2014
Reel 32380, frame 157
Morgan Stanley Senior Funding, Inc., as Administrative AgentEndo Pharmaceuticals Solutions Inc.Release of Patent Security Interest in Exclusively Licensed Patents
Mar 20, 2014
Reel 32491, frame 620
Endo Pharmaceuticals, Inc.Deutsche Bank AG New York Branch, as Collateral AgentGrant of Security Interest in Licensed Patents
Mar 24, 2014
Reel 32513, frame 255
Morgan Stanley Senior Funding, Inc., as Administrative AgentEndo Pharmaceuticals Inc.Corrective Assignment to Correct the Name of Receiving Party in Release of Patent Security Interest in Exclusively Licensed Patents Previously Recorded on Reel 032380 Frame 0157. Assignor(S) Hereby Confirms the Release of Security Interest in Exclusively Licensed Patents..
Apr 28, 2017
Reel 42362, frame 1
Deutsche Bank AG New York BranchEndo Pharmaceuticals, Inc.; Endo Pharmaceuticals Solutions, Inc.; Astora Women's Health Holdings, LLCRelease of Security Interest
Apr 28, 2017
reel/frame not recorded
Deutsche Bank AG New York BranchEndo Pharmaceuticals, Inc.Release of Security Interest
Apr 28, 2017
reel/frame not recorded
Deutsche Bank AG New York BranchEndo Pharmaceuticals Solutions, Inc.Release of Security Interest
Apr 28, 2017
reel/frame not recorded
Deutsche Bank AG New York BranchAstora Women's Health Holdings, LLCRelease of Security Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited